NMPA Approval

Ibuprofen Sustained-release Capsules

Approval Number

国药准字H20123416

Company云鹏医药集团有限公司

Registration Date

September 26, 2022

Previous Approval Numbers

国药准字H20123416

Drug Information

Generic Name

布洛芬缓释胶囊

Brand Name

抗迪

Dosage Form

胶囊剂

Strength

0.3g

Drug Type

化学药品

Registration Date

September 26, 2022

Company Information

Applicant Company

Company Name云鹏医药集团有限公司

Company Address

山西省临汾市襄汾县医药工业园区云鹏大道19号

Manufacturing Company

Company Name云鹏医药集团有限公司

Company Address

山西襄汾医药工业园区云鹏大道19号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

布洛芬缓释胶囊 - NMPA 批准文号 | MedPath